Ovarian morphologyy after prolonged use of steroid contraceptive agents.
D000328:Adult; D002715:Chlormadinone Acetate / Q000494:pharmacology; D003270:Contraceptive Agents / Q000494:pharmacology; D003276:Contraceptives, Oral / Q000494:pharmacology; D003338:Corpus Luteum / Q000187:drug effects; D003560:Cysts / Q000453:epidemiology; D004338:Drug Combinations; D004997:Ethinyl Estradiol / Q000494:pharmacology; D005260:Female; D006801:Humans; D008656:Mestranol / Q000494:pharmacology; D009640:Norethindrone / Q000494:pharmacology; D009649:Norpregnadienes / Q000494:pharmacology; D010049:Ovarian Diseases / Q000453:epidemiology; D006080:Ovarian Follicle / Q000187:drug effects; D010053:Ovary / Q000033:anatomy & histology / Q000187:drug effects / Q000473:pathology; D010298:Parity; D011372:Progestins / Q000008:administration & dosage / Q000494:pharmacology; D013997:Time Factors
D003270:Contraceptive Agents; D003276:Contraceptives, Oral; D004338:Drug Combinations; D009649:Norpregnadienes; D011372:Progestins; D002715:Chlormadinone Acetate; D004997:Ethinyl Estradiol; D008656:Mestranol; D009640:Norethindrone